Tower Research Capital (TRC)’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-500
| Closed | -$1K | – | 4681 |
|
2019
Q1 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 3703 |
|
2018
Q3 | – | Sell |
-1,661
| Closed | -$6K | – | 4519 |
|
2018
Q2 | $6K | Buy |
1,661
+427
| +35% | +$1.54K | ﹤0.01% | 3035 |
|
2018
Q1 | $4K | Sell |
1,234
-7,756
| -86% | -$25.1K | ﹤0.01% | 2826 |
|
2017
Q4 | $28K | Buy |
8,990
+5,734
| +176% | +$17.9K | ﹤0.01% | 1816 |
|
2017
Q3 | $23K | Buy |
3,256
+2,956
| +985% | +$20.9K | ﹤0.01% | 2664 |
|
2017
Q2 | $3K | Sell |
300
-600
| -67% | -$6K | ﹤0.01% | 2284 |
|
2017
Q1 | $10K | Buy |
900
+472
| +110% | +$5.24K | ﹤0.01% | 1808 |
|
2016
Q4 | $3K | Buy |
+428
| New | +$3K | ﹤0.01% | 3337 |
|